A Temporizing Solution to “Artemisinin Resistance”

Three-day therapeutic courses are losing their efficacy against malarial parasites in the Greater Mekong Subregion. But continued rational and strategic use of artemisinin combination treatments is the best, and possibly the only, solution for the foreseeable future.

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 380; no. 22; pp. 2087 - 2089
Main Authors:	Wang, Jigang, Xu, Chengchao, Liao, Fu Long, Jiang, Tingliang, Krishna, Sanjeev, Tu, Youyou
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 30-05-2019
Subjects:	Artemisinin Drug resistance Genotype & phenotype Hemoglobin Infections Malaria Mutation Parasites Ghana Myanmar (Burma) Cambodia Thailand Laos China
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Three-day therapeutic courses are losing their efficacy against malarial parasites in the Greater Mekong Subregion. But continued rational and strategic use of artemisinin combination treatments is the best, and possibly the only, solution for the foreseeable future.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMp1901233